- Home
- HSCS vs EVGN Comparison
HSCS vs EVGN Comparison
Compare HSCS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSCS | EVGN |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | Israel |
| Employees | 12 | N/A |
| Industry | Medical Specialities | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 7.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | HSCS | EVGN |
|---|---|---|
| Price | $2.25 | $0.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $8.00 | $3.50 |
| AVG Volume (30 Days) | 7.2K | ★ 149.8K |
| Earning Date | 03-16-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1,072.41 | N/A |
| Revenue Next Year | $2,700.00 | $73.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.01 | $0.73 |
| 52 Week High | $6.47 | $2.42 |
Technical Indicators
Market Signals| Indicator | HSCS | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 27.17 | 43.80 |
| Support Level | $2.09 | $0.81 |
| Resistance Level | $3.28 | $1.23 |
| Average True Range (ATR) | 0.15 | 0.08 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 3.57 | 33.29 |
Price Performance
Historical ComparisonAbout HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.